Invention Grant
US07939269B2 Method and composition for detecting cancer by means of detection of Epstein-Barr virus nuclear antigen 2 coactivator P100
有权
通过检测爱泼斯坦 - 巴尔病毒核抗原2共激活因子P100检测癌症的方法和组合物
- Patent Title: Method and composition for detecting cancer by means of detection of Epstein-Barr virus nuclear antigen 2 coactivator P100
- Patent Title (中): 通过检测爱泼斯坦 - 巴尔病毒核抗原2共激活因子P100检测癌症的方法和组合物
-
Application No.: US11856107Application Date: 2007-09-17
-
Publication No.: US07939269B2Publication Date: 2011-05-10
- Inventor: Shin Egawa , Hidetoshi Kuruma , Hiroyuki Takahashi , Koji Igarashi
- Applicant: Shin Egawa , Hidetoshi Kuruma , Hiroyuki Takahashi , Koji Igarashi
- Applicant Address: JP Shunan-shi
- Assignee: Tosoh Corporation
- Current Assignee: Tosoh Corporation
- Current Assignee Address: JP Shunan-shi
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2006-250895 20060915; JP2007-049849 20070228
- Main IPC: G01N33/53
- IPC: G01N33/53 ; C12N5/09 ; C07K16/00
Abstract:
The present invention relates to a method for diagnosing cancer and a detection reagent based on detection of Epstein-Barr virus nuclear antigen 2 (EBNA2) coactivator p100 contained in a specimen, and a method for treating cancer by controlling expression of EBNA2 coactivator p100 protein or a gene thereof.
Public/Granted literature
Information query
IPC分类:
